SUDEEPPHRM1,213.50

Sudeep Pharma Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersSUDARSCHEMSTYRENIXSHARDACROPREFEXRCFRALLISRAINPRIVISCLMcap ₹13,706 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations642.3675.6
Other Income28.628.9
Total Income670.8704.5
Expenses
+ Cost of Materials Consumed269.5280.7
+ Changes in Inventories-42.2-39.1
+ Employee Benefit Expense51.954.0
+ Finance Costs7.68.0
+ Depreciation & Amortisation14.815.6
+ Other Expenses141.2147.1
Total Expenses442.8466.2
EBITDA221.9232.9
EBIT207.1217.4
Profit
PBT before Exceptional Items228.1238.3
Pretax Income228.1238.3
+ Current Tax50.950.9
+ Deferred Tax2.93.8
Tax Expense53.854.7
Net Income174.3183.6
+ Net Income — Continuing Ops174.3183.6
+ Other Comprehensive Income-1.21.6
Total Comprehensive Income173.1185.2
Net Income to Common172.9133.1
Minority Interest1.40.8
Per Share
Basic EPS15.5016.46
Diluted EPS15.5016.46
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.21.6
+ Tax on Items NOT to be Reclassified-0.0-0.5
+ Tax on Items to be Reclassified1.2-3.2
Comprehensive Income — Owners of Parent171.7184.2
Comprehensive Income — Non-controlling Interests1.41.0
Per Share — as-filed variants
Basic EPS — Continuing Operations15.5016.46
Diluted EPS — Continuing Operations15.5016.46
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit415.0434.0
Gross Margin %64.6164.24
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)228.1238.3
Net Income Adj (tax-effected)174.3183.6
EPS Adj15.5016.46
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.00
Paid Up Equity Capital11.311.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.